Executive Summary
On January 9, 2026, an unprecedented 41 US companies across diverse sectors filed 8-Ks under Item 5.02 disclosing officer changes, marking a sharp spike in boardroom activity concentrated in a single day. All filings exhibit neutral sentiment, low-to-medium materiality (avg. ~3/10), and pervasive lack of specifics on positions, individuals, appointment/resignation status, or reasons, obscuring true implications. This opacity amid high volume signals potential systemic governance flux or routine compensatory arrangements, urging portfolio managers to monitor for follow-on details amid elevated uncertainty in US equities.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from January 07, 2026.
Investment Signals(4)
- ▲
Unusual single-day volume of 41 officer change filings indicates broad leadership churn risk [BEARISH] - Market-wide
- ▲
Multiple higher-materiality disclosures (4/10) in visible names like Marriott and SoFi suggest near-term volatility potential [BEARISH] - Marriott, SoFi, Oracle
- ▲
No disclosed resignations or distress signals across filings supports stable routine governance [BULLISH] - All companies
- ▲
Cluster of biotech/healthcare changes may reflect sector hiring for innovation [BULLISH] - Pulse Biosciences, Athira Pharma, RadNet
Risk Flags(3)
- (SYSTEMIC)▼
Pervasive NOT_DISCLOSED details (positions, reasons, names) in 100% of filings prevents impact assessment, amplifying uncertainty
- (SYSTEMIC)▼
Concentration of medium-risk filings (80%+) in one day hints at coordinated or hidden executive instability wave
- ▼
Accompanying Items like 7.01 (Reg FD) and 3.02 (equity sales) in select cases (e.g., XTI Aerospace) flag potential undisclosed material events
Opportunities(3)
- ◆
Anticipate detail releases in higher-materiality names (e.g., Marriott, Oracle) for short-term trading alpha on leadership signals
- ◆
Biotech/healthcare cluster (7+ companies) offers entry for fresh leadership-driven catalysts if appointments confirmed
- ◆
Low materiality overall (<4/10 avg.) implies overreaction potential for contrarian longs in affected large-caps like Wynn Resorts
Sector Themes(3)
- ◆
Healthcare/biotech surge (Pulse Bio, Athira, RadNet, Charles River, BioLife, ProPhase) signals possible talent wars or pipeline-driven reshuffles
- ◆
Financials/REITs activity (KKR entities, SoFi, Webster, LendingTree) points to governance tweaks amid rate/macro pressures
- ◆
Scattered transport/manufacturing changes (Polaris, LiveWire, Greenbrier, Sun Country) reflect cyclical sector adjustments
Watch List(4)
- 👁
Marriott International, SoFi Technologies, Oracle - Higher materiality (4/10) with Reg FD exhibits; track for CEO/CFO specifics
- 👁
KKR Real Estate Finance Trust, KKR & Co. - Dual filings in finance/REIT space; monitor for board composition ripple effects
- 👁
Biotech cluster (Athira Pharma, Pulse Biosciences, ProPhase Labs) - Volume suggests sector trend; await reasons for turnover
- 👁
XTI Aerospace - Unique Item 3.02 equity sales alongside officer change; potential dilution/insider signals
Filing Analyses(41)
09-01-2026
SUI Group Holdings Ltd. filed a Form 8-K on January 09, 2026 (AccNo: 0001654954-26-000203, Size: 170 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected officer, position, appointment/resignation, reasons, or quantitative data provided in the filing summary. Sector not specified.
09-01-2026
Koppers Holdings Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001315257-26-000004, Size: 342 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, reason, or quantitative data provided in the summary; sector not specified.
09-01-2026
Marriott International Inc /MD/ filed a Form 8-K on January 09, 2026 (AccNo: 0001193125-26-008335, size 163 KB), disclosing an officer change, departure, election, or compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. Event type is Officer Change from US SEC source. No specific details on affected officers, positions, reasons, or quantitative impacts provided.
09-01-2026
Pulse Biosciences, Inc. disclosed an officer change via Form 8-K filed on January 9, 2026 (AccNo: 0001437749-26-000938, Size: 177 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, appointment/resignation status, reasons, or any quantitative data provided in the filing summary. Sector not specified.
09-01-2026
Hong Yuan Holding Group filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001059, Size: 203 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or nature of change (appointment or departure) are stated.
09-01-2026
Kopin Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001064, size 199 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions, reasons, or terms are provided. Sector not specified.
09-01-2026
Polaris Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001628280-26-001582, size 137 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are provided in the summary. Sector not specified.
09-01-2026
Athira Pharma, Inc. filed an 8-K on 2026-01-09 (AccNo: 0001193125-26-008904) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or named individuals are disclosed. No quantitative data such as transaction values, share counts, or financial metrics are mentioned.
09-01-2026
LiveWire Group, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001898795-26-000008, Size: 174 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details such as the key position affected, individual names, appointment or resignation status, reasons, or any quantitative data are NOT_DISCLOSED in the provided information. Sector is not specified.
09-01-2026
PENN Entertainment, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001140361-26-000833, Size: 245 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided summary.
09-01-2026
Chart Industries Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008906, Size: 136 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details such as the affected officer's name, title (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any quantitative data like compensation amounts are provided in the available information. Sector is not specified.
09-01-2026
The company filed an 8-K on January 9, 2026 (AccNo: 0001104659-26-002461, Size: 285 KB) under Item 5.02 disclosing an officer change event dated January 9, 2026. No specific details on the affected officer's position, appointment or resignation status, reasons, or any quantitative data provided in the filing summary. Sector is not specified.
09-01-2026
BITMINE IMMERSION TECHNOLOGIES, INC. filed a Form 8-K on 2026-01-09 (AccNo: 0001493152-26-001088, Size: 406 KB) disclosing an Officer Change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are disclosed in the provided filing summary. Sector is not specified.
09-01-2026
BANK OF THE JAMES FINANCIAL GROUP INC filed a Form 8-K on January 09, 2026 (AccNo: 0001275101-26-000002, Size: 193 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer, position, reason, or quantitative data provided in the filing summary.
09-01-2026
System1, Inc. disclosed an officer change event via Form 8-K filed on 2026-01-09 (AccNo: 0001805833-26-000003, Size: 145 KB) under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the available information. Sector is not specified.
09-01-2026
Thryv Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001140361-26-000830, Size: 322 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided.
09-01-2026
Charles River Laboratories International, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001628280-26-001603, Size: 142 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual involved, nature of change (appointment or resignation), reasons, or compensation are provided. Sector not specified.
09-01-2026
RadNet, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001683168-26-000190, Size: 217 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Specific details including the key position affected, officer name, appointment or resignation status, reasons, and any quantitative data are NOT_DISCLOSED.
09-01-2026
Community Healthcare Trust Inc filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002475, Size: 200 KB) disclosing an officer change under Item 5.02, covering departures of directors or certain officers, elections or appointments of directors or officers, or compensatory arrangements. Item 9.01 references financial statements and exhibits. No specific details on the officer involved, position, nature of change (appointment or resignation), reasons, or quantitative data are provided.
09-01-2026
Wynn Resorts Ltd filed a Form 8-K on January 9, 2026 (AccNo: 0001174922-26-000004, Size: 392 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, appointment or resignation status, reasons, individuals involved, or any quantitative data are NOT_DISCLOSED. Sector is not specified.
09-01-2026
SoFi Technologies, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001818874-26-000005, Size: 136 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are provided in the filing summary. Sector is not specified.
09-01-2026
Portsmouth Square Inc filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001107, Size: 201 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including key position affected, appointment/resignation status, reasons, or individuals involved are NOT_DISCLOSED.
09-01-2026
KKR Real Estate Finance Trust Inc. disclosed an officer change via Form 8-K filed on January 9, 2026 (AccNo: 0001140361-26-000843, Size: 199 KB) under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the available information. Sector is not specified.
09-01-2026
Microvast Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0000947871-26-000019, Size: 276 KB) disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on the officer involved, position affected, nature of change (appointment/resignation), reasons, or any quantitative data are provided in the filing summary.
09-01-2026
Oracle Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009002, Size: 130 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment or resignation status, reasons, or other impacts are provided in the available information. Sector is not specified.
09-01-2026
KKR & Co. Inc. disclosed an officer change via Form 8-K filed on January 9, 2026 (AccNo: 0001140361-26-000841, Size: 214 KB), under Item 5.02 covering departures, elections, appointments of directors/officers, or compensatory arrangements. Specific details on the officer involved, position, appointment/resignation status, reasons, or impacts are NOT_DISCLOSED. Sector is not specified.
09-01-2026
TENAX THERAPEUTICS, INC. filed a Form 8-K on January 9, 2026 (AccNo: 0001654954-26-000232, Size: 162 KB) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer involved, position, reason, or compensation are provided in the filing summary.
09-01-2026
XMax Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001109, Size: 243 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on positions, individuals, reasons, or quantitative data provided.
09-01-2026
Greenbrier Companies Inc filed an 8-K on January 9, 2026 (AccNo: 0001193125-26-008997, Size: 159 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 5.07 (Submission of Matters to a Vote of Security Holders). No specific details such as affected position, appointment/resignation status, reasons, names, or quantitative data are provided in the filing summary. This is a routine governance disclosure with limited visibility into implications.
09-01-2026
Steven Madden, Ltd. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001108), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific details on the officer, position, reason, or terms are provided in the filing summary.
09-01-2026
Lakeland Industries Inc. filed a Form 8-K on 2026-01-09 (AccNo: 0001193125-26-008983, Size: 144 KB) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.
09-01-2026
LendingTree, Inc. disclosed an officer change via Form 8-K filed on 2026-01-09 (AccNo: 0001683168-26-000191, Size: 211 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, nature of change, or reasons provided.
09-01-2026
Webster Financial Corp filed an 8-K on January 9, 2026 (AccNo: 0000801337-26-000002, Size: 472 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation, reasons, or compensation are provided in the available information. Sector not specified.
09-01-2026
Brink's Co (BRINKS CO) filed an 8-K on January 9, 2026 (AccNo: 0000078890-26-000002, Size: 143 KB) under Item 5.02 disclosing a potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the officer involved, position, reason, or terms are provided in the available summary. Sector not specified.
09-01-2026
Sun Country Airlines Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009087, Size: 137 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
09-01-2026
Caring Brands, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001128, Size: 206 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation provided in the available information. Sector not specified.
09-01-2026
Southern California Gas Co filed a Form 8-K on January 9, 2026 (AccNo: 0000092108-26-000004, Size: 390 KB) under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative data such as compensation amounts or share counts are provided in the summary. Sector is not specified.
09-01-2026
BioLife Solutions Inc (BIOLIFE SOLUTIONS INC) filed an 8-K on January 9, 2026 (AccNo: 0001628280-26-001649, Size: 135 KB), disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions, individuals, reasons, or compensation provided; sector not specified.
09-01-2026
Janus International Group, Inc. disclosed an officer change via Form 8-K filed on January 9, 2026 (AccNo: 0001104659-26-002536, Size: 186 KB) under Item 5.02, covering departures, elections, appointments of directors or certain officers, and compensatory arrangements. No specific details on individuals, positions, reasons, or terms provided in the available information. Sector not specified.
09-01-2026
ProPhase Labs, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001134, size 200 KB), disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements. No specific details on the affected officer's name, title (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data such as compensation are provided in the summary. Sector is not specified.
09-01-2026
XTI Aerospace, Inc. filed a Form 8-K on January 09, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Item 3.02 (Unregistered Sales of Equity Securities) and Item 9.01 (Financial Statements and Exhibits). No specific details on positions, individuals, reasons, or numerical data are provided in the summary.
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 41 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings